论文部分内容阅读
目的:观察罗通定治疗海洛因依赖稽延性戒断症状的临床疗效。方法:将60例海洛因依赖强制隔离戒毒人员随机分2组,罗通定组和对照组,每组30例。完成一疗程治疗后观察停药第1天、停药第30天的临床疗效,采用《稽延性戒断症状评定量表》评分对疗效进行评价。结果:罗通定组对稽延性戒断症状的治疗效果与对照组比较存在显著差异(P<0.01)。结论:罗通定对治疗海洛因依赖者的稽延性戒断症状有显著疗效,并且安全、简便,适合强制隔离戒毒场所人员稽延性戒断症状的治疗。
Objective: To observe the clinical efficacy of Luo Tongding in the treatment of protracted withdrawal symptoms of heroin addicts. Methods: Sixty cases of heroin dependence compulsive isolation and detoxification were randomly divided into two groups: Luo Tongding group and control group, 30 cases in each group. After the completion of a course of treatment observed on the first day of withdrawal, the first 30 days of withdrawal of clinical efficacy, the use of “protracted withdrawal symptoms rating scale” score to evaluate the efficacy. Results: The results of treatment of protracted withdrawal symptoms in LuoTuoDing group were significantly different from those in control group (P <0.01). Conclusion: Luo Tongding treatment of protracted withdrawal symptoms of heroin addicts have a significant effect, and safe, simple, suitable for mandatory isolation of patients with protracted withdrawal syndrome treatment.